Corpus ID: 25695813

The rate of invasive testing for trisomy 21 is reduced after implementation of NIPT.

  title={The rate of invasive testing for trisomy 21 is reduced after implementation of NIPT.},
  author={L. Bjerregaard and Anne Betsagoo Stenbakken and Camilla Skov Andersen and L. Kristensen and C. V. Jensen and P. Skovbo and A. N. S{\o}rensen},
  journal={Danish medical journal},
  volume={64 4}
INTRODUCTION The non-invasive prenatal test (NIPT) was introduced in the North Denmark Region in March 2013. NIPT is offered as an alternative to invasive tests if the combined first trimester risk of trisomy 21 (T21) is ≥ 1:300. The purpose of this study was to investigate the effect of NIPT implementation among high-risk pregnancies in a region with existing first-trimester combined screening for T21. The primary objective was to examine the effect on the invasive testing rate. METHODS This… Expand
8 Citations
Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis.
  • X. Xie, M. Wang, +13 authors Vivian Ng
  • Medicine
  • Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
  • 2020
  • 2
Creating basis for introducing NIPT in the Estonian public health setting
  • 2
  • PDF


Overview of the impact of noninvasive prenatal testing on diagnostic procedures
  • 89
  • PDF
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening
  • 128
  • PDF
The Danish Fetal Medicine database
  • 14
  • PDF
Potential diagnostic consequences of applying non‐invasive prenatal testing: population‐based study from a country with existing first‐trimester screening
  • 102
A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A
  • 584
  • PDF
Chromosomal microarray in fetuses with increased nuchal translucency
  • 44
Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease.
  • 117